Chicago Partners Investment Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-38,891
Closed -$1.06M 583
2021
Q4
$1.06M Buy
38,891
+5,080
+15% +$204K 0.08% 214
2021
Q3
$1.34M Buy
+33,811
New +$1.23M 0.09% 183

Other funds holding GDRX

Chicago Partners Investment Group's GDRX Position: Q1 2022 in Review

Chicago Partners Investment Group sold out of GoodRx Holdings (GDRX) in Q1 2022, closing a stake of 38,891 shares — an estimated $1.06M sold.

Chicago Partners Investment Group first reported a position in GDRX in Q3 2021 and held it in 2 quarters. The position peaked at $1.34M in Q3 2021. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

  • Chicago Partners Investment Group reported no remaining GoodRx Holdings position as of Q1 2022 after selling out during the quarter.
  • Chicago Partners Investment Group sold 38,891 GoodRx Holdings shares in Q1 2022, an estimated $1.06M.
  • Chicago Partners Investment Group first reported a position in GoodRx Holdings in Q3 2021 and held it in 2 quarters.
  • Chicago Partners Investment Group's GoodRx Holdings position peaked at $1.34M in Q3 2021.
  • 167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on Chicago Partners Investment Group's 13F filing for Q1 2022, filed 20 May 2022.